Catalyst Wire Dossier Catalyst Wire Dossier

Laropiprant

laropiprant
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Laropiprant, covering 2008-11-27 to 2019-10-08. Get the full timeline:

Most recent: Clinical Trial Update: ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART [Phase 4]

See pricing